GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $363,000 | +0.6% | 8,345 | +0.6% | 0.02% | +14.3% |
| Q1 2022 | $361,000 | -1.4% | 8,295 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $366,000 | -2.9% | 8,295 | -16.0% | 0.01% | -7.1% |
| Q3 2021 | $377,000 | +1.9% | 9,870 | +6.2% | 0.01% | 0.0% |
| Q2 2021 | $370,000 | +26.3% | 9,294 | +13.4% | 0.01% | +16.7% |
| Q1 2021 | $293,000 | -10.4% | 8,194 | -5.9% | 0.01% | -20.0% |
| Q3 2020 | $327,000 | -6.3% | 8,704 | +1.8% | 0.02% | -11.8% |
| Q2 2020 | $349,000 | -27.4% | 8,554 | -32.6% | 0.02% | -39.3% |
| Q1 2020 | $481,000 | -24.7% | 12,698 | -6.7% | 0.03% | -3.4% |
| Q4 2019 | $639,000 | -1.1% | 13,603 | -10.1% | 0.03% | -9.4% |
| Q3 2019 | $646,000 | +6.6% | 15,136 | 0.0% | 0.03% | +6.7% |
| Q2 2019 | $606,000 | -7.9% | 15,136 | -3.8% | 0.03% | -9.1% |
| Q1 2019 | $658,000 | +48.2% | 15,741 | +35.4% | 0.03% | +26.9% |
| Q4 2018 | $444,000 | -9.0% | 11,629 | -4.2% | 0.03% | +8.3% |
| Q3 2018 | $488,000 | -0.2% | 12,140 | 0.0% | 0.02% | -4.0% |
| Q2 2018 | $489,000 | -3.7% | 12,140 | -6.7% | 0.02% | -3.8% |
| Q1 2018 | $508,000 | +14.4% | 13,015 | +4.0% | 0.03% | -13.3% |
| Q4 2017 | $444,000 | -14.3% | 12,515 | -2.0% | 0.03% | +11.1% |
| Q3 2017 | $518,000 | -6.0% | 12,765 | 0.0% | 0.03% | -10.0% |
| Q2 2017 | $551,000 | +2.4% | 12,765 | 0.0% | 0.03% | 0.0% |
| Q1 2017 | $538,000 | +12.6% | 12,765 | +2.8% | 0.03% | +11.1% |
| Q4 2016 | $478,000 | -15.5% | 12,415 | -5.4% | 0.03% | -18.2% |
| Q3 2016 | $566,000 | +6.0% | 13,125 | +6.5% | 0.03% | +3.1% |
| Q2 2016 | $534,000 | +6.0% | 12,325 | -0.8% | 0.03% | +6.7% |
| Q1 2016 | $504,000 | -3.1% | 12,425 | -3.6% | 0.03% | -3.2% |
| Q4 2015 | $520,000 | -27.8% | 12,884 | -31.2% | 0.03% | -29.5% |
| Q3 2015 | $720,000 | -24.4% | 18,736 | -18.1% | 0.04% | -17.0% |
| Q2 2015 | $953,000 | +6.8% | 22,866 | +18.2% | 0.05% | +8.2% |
| Q1 2015 | $892,000 | +10.8% | 19,346 | +2.7% | 0.05% | +11.4% |
| Q4 2014 | $805,000 | -3.0% | 18,846 | +4.4% | 0.04% | -6.4% |
| Q3 2014 | $830,000 | -26.7% | 18,054 | -14.7% | 0.05% | -25.4% |
| Q2 2014 | $1,132,000 | -12.2% | 21,174 | -12.3% | 0.06% | -13.7% |
| Q1 2014 | $1,290,000 | -11.3% | 24,144 | -11.4% | 0.07% | -12.0% |
| Q4 2013 | $1,455,000 | +10.9% | 27,241 | +4.2% | 0.08% | +2.5% |
| Q3 2013 | $1,312,000 | +1.9% | 26,151 | +1.6% | 0.08% | -3.6% |
| Q2 2013 | $1,287,000 | – | 25,751 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |